Michael Bayewitch, PhD
Insilico Medicine Appoints Michael Bayewitch as VP, Business Development and Strategy
15. Mai 2023 13:34 ET | InSilico Medicine
Abu Dhabi, May 15, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has appointed Michael Bayewitch, PhD, as Vice...
Michael Bayewitch, PhD
Insilico Medicine Appoints Michael Bayewitch as VP, Business Development and Strategy
15. Mai 2023 13:20 ET | InSilico Medicine
Hong Kong, May 15, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has appointed Michael Bayewitch, PhD, as Vice...
Disease Modeling and Target Identification Course from Insilico Medicine
UAE Biotech Insilico Medicine Offers Disease Modeling and Target Identification Course Using AI
12. Mai 2023 08:40 ET | InSilico Medicine
Abu Dhabi, May 12, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine, a generative artificial intelligence (AI)-driven drug discovery company, announced that it is releasing a course on Disease Modeling...